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ABSTRACT
The mechanisms by which insulin modulates neuronal plasticity and pain processes remain poorly understood. Here we report that insulin rapidly increases the function of 
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Insulin has been extensively studied as a regulator of metabolic processes;
however, its role in regulating neuronal transmission has only recently been explored.
Insulin diffuses into the central nervous system from peripheral sources and is also produced in the brain where it binds to cell surface receptors and activates a variety of signaling molecules (Schulingkamp et al., 2000) . Neurons can secrete insulin in a calcium-dependent manner when depolarized (Clarke et al., 1986) . Further, insulin receptors and their substrates are widely expressed in the brain and spinal cord. In particular, insulin receptors are predominantly located in laminas V and X of the spinal cord, which suggests involvement in sensory pathways (Sugimoto et al., 2002) . Clinical disorders resulting from a deficiency of insulin, such as diabetes mellitus, are characterized by neuropathic pain (for reviews, see Park, 2001 ). The acute administration of insulin reduces the concentration of inhaled anesthetic that is required to prevent movement in response to a painful stimulus in a rat model (Xing et al., 2004) . This acute anesthetic-sparing effect of insulin is independent of effects on the concentration of blood glucose. The molecular basis for the analgesic properties and alterations in neurotransmission by insulin has not been elucidated.
Glycine receptors (GlyRs) are the major sites of fast synaptic inhibition in the spinal cord and brainstem (Lynch, 2004) . GlyRs in neurons are pentameric complexes assembled from two classes of subunits (α 1-4 , conductance and determining receptor sensitivity to a variety of pharmacological compounds (Laube et al., 2002) . Native GlyRs are known to play fundamental roles in motor and sensory processes, including the coordination of movement and nociception (Legendre, 2001 ).
Several lines of evidence predict that insulin modifies GlyR function. Firstly, insulin alters the function and surface expression of several members of the evolutionarily conserved superfamily of channels to which GlyRs belongs. Insulin increases currents generated by γ -aminobutyric acid subtype A (GABA A ) receptors by increasing the number of receptors expressed at the membrane surface (Wan et al., 1997) .
In addition, the insulin receptor is a member of the family of receptor tyrosine kinases that activates a number of second messenger systems involving protein kinase C (PKC), non-receptor tyrosine kinases, and phosphatidylinositol 3 (PI3) kinase (for review, see Saltiel and Pessin, 2002) . The function of GlyRs is regulated by PKC, for which both enhancement and depression of glycinergic currents have been reported (Legendre, 2001 ). GlyR function is also up-regulated by the non-receptor tyrosine kinase c-Src, which increases receptor function possibly via actions on a tyrosine residue at position 413 of the β subunit (Caraiscos et al., 2002) . Given these results, we tested the hypothesis that insulin modulates GlyRs. Using electrophysiological and immunoimaging techniques, we showed that insulin up-regulates GlyR function by increasing the potency of glycine in a manner that is dependent on cytosolic signaling pathways involving tyrosine kinases and PI3 kinase.
Material and Methods
Spinal cord cell cultures
Primary cultures of spinal cord neurons were prepared from embryonic Swiss white mice. In brief, fetal pups (13 to 14 days in utero) were removed from mice sacrificed by cervical dislocation. The spinal cord of each fetus was collected for plating.
Neurons were plated on collagen-coated 35 mm dishes at a density of 1 x 10 6 and were grown in MEM (Invitrogen, Carlsbad, California, USA) supplemented with 10% fetal bovine serum (FBS; Invitrogen, Carlsbad, California, USA), 10% horse serum 
Electrophysiology
Spinal neurons were voltage clamped at -60 mV using standard whole cell patch clamp techniques. The extracellular solutions were applied to the neurons using a computer-controlled, multi-barreled perfusion system with an exchange time of about 3 ms (SF-77B; Warner Inst., Hamden, Connecticut, USA). To monitor access resistance, a voltage step of -10 mV was applied before each application of glycine. Some experiments were performed using the gramicidin (Sigma-Aldrich Canada, Oakville, Canada) perforated-patch technique (Akaike, 1996) . The pipette solution contained (in mM) 150 K-gluconate and 10 HEPES with the pH adjusted to 7.3 using KOH. The osmolarity of the solution was adjusted to 290-300 mOsm using sucrose.
Gramicidin stock solution (10 mg/ml in methanol) was diluted in the pipette solution to a final concentration of 50 to 100 HNMPA, glycine-evoked currents were allowed to reach a stable amplitude over 5 sec before drugs were applied as previously described (Caraiscos et al., 2002) .
Glycinergic mIPSCs were recorded in the presence of TTX and analyzed with Mini Analysis software (Synaptosoft, NJ, USA). For detection, the detection threshold was set at approximately three times higher than the level of baseline noise for each neuron. In addition, each file was manually inspected to reject spurious events caused by excessive noise and to include any events that were not detected by the program. All events with a 10-90% rise time of less than 5 ms were used in the analysis. The peak amplitude, 10-90% rise time, charge transfer (Q) and the time constant of current decay (τ decay ) were analyzed. Peak amplitude refers to the maximum height of the mIPSC and rise time refers to the time elapsed between 10% and 90% of the peak amplitude response. All events recorded from each cell under each experimental condition were This article has not been copyedited and formatted. The final version may differ from this version. 
Immunocytochemistry
The surface expression of GlyRs was studied using native receptors and The c-myc tag was introduced so that α 1 GlyRs could be stained and visualized using confocal microscopy. The c-myc epitope was inserted after the second amino acid of the extracellular C terminus of the GlyR Immunostaining was visualized with a laser-scanning confocal microscope (Leica TCS SL, Leica Microsystem Heidelberg GmbH, Germany). All cultures were imaged using identical confocal settings at maximum projection throughout all optical sections using Leica Confocal Software (Leica Microsystem Heidelberg GmbH, Germany) functions.
Total surface fluorescence intensity was quantified using Scion Image software (Scion Image Beta 4.03, Scion Corporation, Maryland, USA).
Data analysis and statistical tests
Currents were recorded and analyzed with pCLAMP6 software (Axon Instruments Inc., Foster City, California, USA 
Results
Insulin increases the function of GlyRs in spinal neurons
Currents were evoked by applying a sub-saturating concentration of glycine (15 µ M) (Caraiscos et al., 2002) Heat-inactivated insulin (1 µ M) failed to enhance current evoked by glycine (99% ± 3% of control, n = 5). Insulin (1 µ M) applied alone in the absence of glycine did not generate a current as the holding current remained unchanged (104% ± 1% of control, n = 6). Coapplication experiments indicated that the onset of insulin enhancement of I Gly was rapid as it occurred within the timescale of the perfusion system (about 3 milliseconds).
Enhancement of I Gly was similar whether insulin was pre-applied for 60 s or co-applied with glycine (139% ± 5% of control, n = 16, p < 0.05 and 143% ± 7% of control, n = 7, p < 0.05, respectively; Fig. 1C ). Recovery from the insulin effect was studied by pretreating neurons with insulin (1 µ M) for 5 min, then applying an insulin-free extracellular solution. Within 1 min of insulin washout, the glycine current had an amplitude that was similar to control (107% ± 3% of control, n = 10; Fig. 1D ). Ten minutes after washout, insulin was re-applied and I Gly enhanced to 140% ± 10% of control (n = 7, p < 0.05).
Thus, insulin caused a rapid, reversible, and reproducible increase in I Gly .
This article has not been copyedited and formatted. The final version may differ from this version. Next, to determine whether insulin altered the equilibrium potential for chloride ions, the effect of insulin on the current-voltage relationship for I Gly was examined.
Insulin (1 µ M) increased the slope conductance (15 ± 2 nS for control vs. 21 ± 4 nS for insulin, n = 4, p < 0.05, n = 4) but did not change the reversal potential which was similar to the Nernst potential for chloride ions (about -16 mV) ( Fig. 1 E and F) . Enhancement of GlyRs by insulin occurred at both hyperpolarizing and depolarizing membrane potentials.
Insulin increases the potency of glycine in spinal neurons
Enhancement of I Gly by insulin could result from either direct potentiation of GlyRs or recruitment of new functional receptors to the plasma membrane or a combination of these effects. We predicted that if the number of functional receptors increased, the current activated by a saturating concentration of glycine would increase, as has been observed for GABA A receptors (Wan et al., 1997) . Current activated by a saturating concentration of glycine (1 mM) was not enhanced by insulin (1 µ M) (n = 5; This article has not been copyedited and formatted. The final version may differ from this version. (Laube et al., 1995) . Synaptic Zn 2+ is essential for proper in vivo functioning of glycinergic synaptic transmission (Hirzel et al., 2006) . To determine whether trace levels of Zn 2+ accounted for or contributed to insulin enhancement of I Gly , two strategies were used. First, we We also examined the effect of insulin on I Gly recorded from neurons that had been grown in insulin-free media. Neurons grown in insulin-free media did not appear as healthy as controls as cell density and lifespan were lower than controls. The increase in I Gly by insulin with tricine in the extracellular solution (125 ± 7% of control, p < 0.05, n = 3) was not different for neurons grown in insulin-free media.
The α subunit is sufficient for insulin enhancement of I Gly
Insulin modulation of several transmitter-gated ion channels depends on the subunit composition of the underlying receptors. For example, insulin potentiates NMDA receptors in a subunit-specific manner through signaling pathways involving PKCs (Jones and Leonard, 2005) . Similarly, enhancement of GABA A receptors by insulin depends on the subunit complement of the receptors and involves tyrosine kinasedependent pathways (Wan et al., 1997) . We previously reported that tyrosine kinases upregulate I Gly by mechanisms that require the β subunit (Caraiscos et al., 2002 ). Thus, we tested the hypothesis that enhancement of I Gly by insulin involves second messenger systems that require the β subunit. Also, since the subunit composition of native GlyRs in cultured spinal neurons is unknown; we sought to determine whether the adult heteromeric GlyRs (118% ± 4% of control, n = 7, P < 0.05 and 120% ± 4% of control, n = 14, p < 0.05, respectively; Fig. 3 ).
Hence, the β subunit is not required for the insulin enhancement of GlyRs and homomeric α 1 GlyRs are sensitive to insulin.
Insulin potentiation of I Gly is mediated by the insulin receptor
To determine whether activation of the insulin receptor is required for the effects of insulin on I Gly , we applied a compound that inhibits insulin receptor function. The membrane-permeable inhibitor HNMPA antagonizes both activity and autophosphorylation of insulin receptor tyrosine kinase (Saperstein et al., 1989) (Saperstein et al., 1989) . To examine the effects of HNMPA and insulin in the same cell, the experimental protocol was slightly modified. Together, the results show that enhancement of I Gly requires activation of the insulin receptor.
Insulin potentiation of I Gly involves PI3 kinase and tyrosine kinases
The insulin receptor is a member of the superfamily of receptor tyrosine kinases.
It is a dimer composed of two extracellular and its inactive analogue lavendustin B (10 µ M), were examined in spinal neurons. We previously reported that lavendustin A and lavendustin B cause a rapid, reversible direct inhibition of GlyRs by approximately 35% which is independent of actions on tyrosine kinases (Caraiscos et al., 2002) . Lavendustin A caused a further 40% decrease in I Gly in spinal neurons compared to lavendustin B via mechanisms involving tyrosine kinases This article has not been copyedited and formatted. The final version may differ from this version. (Caraiscos et al., 2002) . In the present experiments, glycine was repeatedly applied until the currents stabilized in the presence of either lavendustin A or lavendustin B. Insulin was subsequently applied and the change in I Gly was measured. The inactive analogue lavendustin B (10 µ M) had no effect on insulin enhancement of I Gly as the current was increased to 137% ± 7% of control (n = 7; p < 0.05). In contrast, lavendustin A completely abolished the enhancement of I Gly by insulin (98% ± 4% of control, n = 7; This article has not been copyedited and formatted. The final version may differ from this version. 
Gramicidin perforated patch recordings
Under our recording conditions, the intracellular solution (in the electrode) contained a high concentration of chloride ions which has been shown to influence intracellular signaling pathways (Lenz et al., 1997) . In addition, the conventional whole cell patch configuration alters cytosolic constituents of signaling pathways and calcium buffering systems. To determine whether changes in the intracellular concentration of chloride ions or dilution of cytosolic substrates influenced the actions of insulin on I Gly , we performed perforated patch recording using the gramicidin technique (Akaike, 1996) .
The increase in I Gly by insulin (1 µ M) was similar for currents recorded using whole cell and gramicidin perforated patch techniques (143% ± 7% of control, n = 7 versus 147% ± 15% of control, n = 6, respectively, p > 0.05). Thus, dialysis of intracellular constituents and disruption of the physiological chloride ion gradient did not alter insulin modulation of GlyR function.
Insulin increases inhibitory glycinergic synaptic transmission in spinal neurons
To examine the effects of insulin on glycinergic synaptic transmission, spontaneous mIPSCs were recorded from cultured spinal neurons in the presence of ionotropic glutamate receptor antagonists and GABA A receptor antagonists. At least eight different sets of cultures were used for these experiments and each culture dish was used to record from only one cell. Insulin (1 µ M) increased the amplitude of mIPSCs to 124% ± 4% of control (38.9 ± 7.4 pA for control and 47.4 ± 8.8 pA for insulin, n = 8, p < 0.05; did not change the interspike time interval (11.5 ± 1.5 ms for control and 11.3 ± 1.8 ms for insulin), rise time (10-90%: 1.3 ± 0.2 ms for control and 1.3 ± 0.1 ms for insulin) or decay time (11.5 ± 1.5 ms for control and 11.3 ± 1.8l ms for insulin). The GlyR antagonist strychnine (1 µ M) abolished the insulin-sensitive mIPSCs (n = 5; Fig. 6 ),
confirming that the currents were generated by GlyRs.
We next sought to determine whether a tonic glycinergic current is generated by cultured spinal neurons. The tonic glycinergic current was detected by applying strychnine (1 µ M) and measuring the change in the holding current. Strychnine (1
failed to reduce the holding current (0.45 pA ± 1.3 pA, n = 7, p > 0.05) indicating the absence of a tonic glycinergic current. Consistent with this result, the application of insulin alone failed to alter the holding current (104% of control as reported above).
Thus, insulin increases synaptic but not tonic glycinergic currents in cultured spinal neurons.
Insulin does not affect GlyR surface expression in HEK 293 cells and spinal neurons
The above results are consistent with insulin causing an increase in the function of GlyRs rather than an increase in the number of functional GlyRs expressed at the plasma membrane. However, insulin has previously been shown to stimulate the recruitment of functional GABA A and NMDA receptors to the plasma membrane (Wan et al., 1997; Skeberdis et al., 2001) . It is possible that insulin also increased the surface expression of GlyRs but they remained inactive. To examine the effects of insulin on the expression of GlyRs, immunocytochemistry was used to visualize human recombinant c- 
Together, these results indicate that insulin does not change the number of functional
GlyRs at the plasma membrane.
This article has not been copyedited and formatted. The final version may differ from this version. The results showed that insulin caused a rapid and reversible increase in GlyR function.
The potency of glycine was increased via mechanisms that involved, at least in part, the insulin receptor, PI3 kinase and tyrosine kinases. The adult α 1 subunit isoform was both sensitive and sufficient for insulin to induce an effect.
Insulin actions on GlyRs are fundamentally different from those that modify NMDA and GABA A receptors. Insulin enhancement of NMDA receptors results from the delivery of new channels to the cell membrane via SNARE-dependent exocytosis (Wan et al., 1997; Skeberdis et al., 2001) . Enhancement of GABA A receptors in hippocampal neurons occurs via recruitment of new receptors to the cell membrane (Wan et al., 1997) .
These mechanisms contrast those that underlie insulin modulation of GlyRs as agonist potency rather than the number of functional GlyRs is increased. Despite such differences, insulin modulation of glycine, NMDA and GABA A receptors share several common features. Carbachol enhancement of GABA A receptors in cortical pyramidal neurons only occured when neurons were pretreated with insulin. This insulin-induced enhancement of GABA A receptors was dependent on PKC, protein tyrosine kinase Srcmediated signaling cascades and PI3 kinase-dependent pathways (Ma et al., 2003) .
Insulin up-regulated postsynaptic GABA A receptors and increased the amplitude of spontaneous mIPSCs recorded in hippocampal CA1 neurons without altering the time course of mIPSC activation or decay (Wan et al., 1997) . Similarly, we showed that insulin enhanced the amplitude but not the frequency of glycinergic mIPSCs in spinal This article has not been copyedited and formatted. The final version may differ from this version. neurons suggesting a postsynaptic rather than presynaptic site of action. Insulin potentiated NMDA receptor-mediated currents via activation of the insulin receptor tyrosine kinase as potentiation was eliminated by HNMPA (Skeberdis et al., 2001 ).
Interestingly, a study of recombinant NMDA receptors that lacked all known sites of tyrosine and serine/threonine phosphorylation showed that insulin potentiation did not require direct phosphorylation of the NMDA receptor (Skeberdis et al., 2001) . Insulin enhancement of GlyR function did not require the β subunit. Since the β subunit is required for up-regulation of GlyRs by the protein tyrosine kinase cSrc (Caraiscos et al., 2002) , direct phosphorylation by Src does not contribute to insulin potentiation of GlyRs.
Insulin enhancement of GlyRs was mediated by pathways involving the insulin receptor and PI3 kinase. The cell signaling networks that are regulated by the insulin receptor are complex and contain multiple and divergent signaling cascades (for review see Taniguchi et al., 2006) . Insulin binding to its receptor causes phosphorylation of insulin receptor substrate proteins (IRS proteins) which recruit the Src homology 2 domain-containing lipase kinase, PI3 kinase. PI3 kinase catalyzes phosphorylation of phosphoinositides on the 3-position to produce phosphatidylinositol (3,4,5) triphosphate (Reichardt, 2006) . A variety of downstream second messenger systems use phosphatidylinositol (3,4,5) triphosphate including MAPK and stress-induced protein kinase. Growth factors and insulin may share similar actions on GlyRs as the activation of insulin-like-growth factor-1 (IGF-1) receptor rapidly (within seconds) increases the potency of taurine for GlyRs; however the actions of IGF-1 were independent of PI3 kinase pathways as they are insensitive to wortmannin (Ster et al., 2005) .
This article has not been copyedited and formatted. The final version may differ from this version. Yevenes et al., 2003) . Studies using mutant GlyRs showed that two basic amino acids within the large intracellular loop of the GlyR ambient concentrations of glycine (Lynch, 2004) . The tonic glycinergic inhibition generated in these regions may be enhanced by insulin. Cultured spinal neurons do not generate a tonic glycinergic conductance, possible due to either a low concentration of agonist or too few extrasynaptic GlyRs. This result is consistent with the absence of a tonic glycinergic current in the lamina II region of spinal cord in the adult mice (Ataka and Gu, 2006) .
Insulin effects were studied primarily using embryonic not mature neurons. The complement of GlyR subunits in cultured spinal neurons is uncertain as the expression of subunits changes at various ontogenic stages and during postnatal development (Legendre, 2001; Aguayo et al., 2004) . The been studied using electrophysiology and RT-PCR analysis of mRNA (Aguayo et al., 2004) . In rat spinal cord neurons prepared at 14 days of gestation and studied up to 10 DIV, the expression of DIV to levels close to that observed at 1 DIV. Thus, the adult isoform of the GlyR likely contributes to the insulin-sensitive I Gly in cultured spinal neurons.
The concentration of insulin in the brain is unknown but may be as high as 0.02 Havrankova et al., 1978) . The lowest concentration of insulin that increased I Gly was 1 µ M, suggesting that a pharmacological rather than a physiological concentration of insulin enhances I Gly . However, it is plausible that GlyRs localized in proximity to insulin release sites may be exposed to high concentrations of insulin. Insulin has a wide spectrum of actions and whether effects on GlyRs account for or contribute to the analgesic properties of insulin remain to be determined. Both GlyRs and insulin have been implicated in pain processes; however this report provides the first evidence of an interaction between these two factors. The GlyR is the main inhibitory receptor in the spinal cord and brainstem; hence, insulin regulation of glycinergic activity may influence physiological processes regulated by these structures. Indeed, behavioral studies have showed that insulin influenced pain transduction at the level of the spinal cord (Courteix et al., 1996; Takeshita and Yamaguchi, 1997) . Previous studies have implicated reduction in the function and/or number of GlyRs in neuropathic pain (Simpson, Jr. et al., 1996; Simpson, Jr. and Huang, 1998) , allodynia (Yaksh, 1989; Sorkin and Puig, 1996) and hyperalgesia (Beyer et al., 1985; Beyer et al., 1988) , which suggests that glycinergic neurons may modulate afferent transmission relating to pain. Insulin acted as an analgesic agent in animal models as it attenuated formalin-induced nociceptive responses in normal mice, independent of plasma glucose levels (Takeshita and Yamaguchi, 1997) . Further, chronic insulin treatment relieved long-term hyperalgesia in mice with streptozocininduced diabetes (Courteix et al., 1996) and exerted antinociception in both This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. 
